Pain Relievers Market SWOT Analysis by 2031
The Pain Relievers Market is expected to register a CAGR of 9.1% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The Pain Relievers market report is segmented by type into Nonsteroidal Anti-inflammatory Drugs and Central Analgesics. The application segment includes Headache, Toothache, Arthralgia, and Menstrual Pain. The market evaluation is presented in US$ for the above segmental analysis.
Purpose of the ReportThe report Pain Relievers Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Pain Relievers Market Segmentation
Type- Nonsteroidal Anti-inflammatory Drugs
- Central Analgesics
- Headache
- Toothache
- Arthralgia
- Menstrual Pain
Strategic Insights
Pain Relievers Market Growth Drivers- Aging Population: The aging population, which is more prone to chronic pain, is accelerating the growth of the pain reliever market.
- Advancements in Pharmaceuticals: New and improved pain relief pharmaceuticals, developed through ongoing research and development, are contributing to market expansion.
- Increased Healthcare Accessibility: Rising healthcare expenses and the increasing accessibility of healthcare in developing countries are boosting the market for pain relievers.
- Shift Toward Non-Opioid Drugs: The rising concern over opioid overdose and addiction is driving the demand for non-opioid pain relievers and their novel combinations.
- Advancements in Drug Delivery Systems: New drug delivery systems, such as topical patches and oral disintegrating tablets, are improving patient compliance and the effectiveness of pain treatments.
- Personalized Medicine Growth: Tailored treatment based on an individual's genetic profile and pain phenotype is becoming more popular in the pursuit of personalized pain relief. Tailored treatment to an individual's genetic profile and pain phenotype is gaining momentum for personalized medicine.
- Rising Awareness and Self-Care: Growing awareness of pain management and the increasing desire for self-care are driving the demand for over-the-counter pain relievers. Increasing awareness of pain management and the desire for self-care also enhances the demand for over-the-counter pain relievers.
- Opportunities for Innovative Therapies: The market is opening up for innovative pain management pharmacotherapies, such as targeted drug delivery systems and combination therapies.This would create the window for innovative pain management pharmacotherapies to become available in the marketplace - targeted drug delivery systems as well as combination therapies among others.
- Advancements in Digital Health: Digital health technologies, like wearables and telemedicine, are providing new opportunities for improved pain monitoring and management remotely. Digital health may also come in the shape of wearables and telemedicine for improved monitoring of pain, and management with remote settings, offering space for innovations to flourish.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Pain Relievers Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Pain Relievers Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Pain Relievers Market is expected to grow at a CAGR of 9.1% between 2023-2031
The pain relievers market is driven by several factors. The increasing prevalence of chronic pain conditions such as arthritis, back pain, and migraines is a major driver. The aging population, which is more susceptible to chronic pain, further fuels market growth. Advancements in pharmaceutical research and development are leading to the introduction of more effective and safer pain relief solutions. Increasing healthcare expenditure and increased access to healthcare in developing countries are also contributing to market expansion.
Several key trends characterize the future of the pain relievers market. There is a large shift toward non-opioid pain management solutions in light of the opioid addiction issue. This is promoting the development of innovative non-opioid analgesics and combination therapies. Improvements in drug delivery systems, such as topical patches and oral disintegrating tablets, are also enhancing patient compliance and efficacy. Personalized medicine is increasingly becoming prominent, with tailored treatment approaches based on individual genetic profiles and pain phenotypes. The integration of digital health technologies, including wearable devices and telemedicine, is enhancing pain monitoring and remote management. Moreover, the growing interest in natural and complementary therapies is creating new opportunities in the pain relief market.
The leading players of the market are: Pfizer, Endo Pharmaceuticals, Bayer AG, GSK, AstraZeneca, Grunenthal, Eli Lilly and Company, Sanofi, Merck, Purdue Pharma
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pain Relievers Market - By Type
1.3.2 Pain Relievers Market - By Application
1.3.3 Pain Relievers Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PAIN RELIEVERS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PAIN RELIEVERS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PAIN RELIEVERS MARKET - GLOBAL MARKET ANALYSIS
6.1. PAIN RELIEVERS - GLOBAL MARKET OVERVIEW
6.2. PAIN RELIEVERS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PAIN RELIEVERS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
7.3.1. Overview
7.3.2. Nonsteroidal Anti-inflammatory Drugs Market Forecast and Analysis
7.4. CENTRAL ANALGESICS
7.4.1. Overview
7.4.2. Central Analgesics Market Forecast and Analysis
8. PAIN RELIEVERS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HEADACHE
8.3.1. Overview
8.3.2. Headache Market Forecast and Analysis
8.4. TOOTHACHE
8.4.1. Overview
8.4.2. Toothache Market Forecast and Analysis
8.5. ARTHRALGIA
8.5.1. Overview
8.5.2. Arthralgia Market Forecast and Analysis
8.6. MENSTRUAL PAIN
8.6.1. Overview
8.6.2. Menstrual Pain Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. PAIN RELIEVERS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Pain Relievers Market Overview
9.1.2 North America Pain Relievers Market Forecasts and Analysis
9.1.3 North America Pain Relievers Market Forecasts and Analysis - By Type
9.1.4 North America Pain Relievers Market Forecasts and Analysis - By Application
9.1.5 North America Pain Relievers Market Forecasts and Analysis - By Countries
9.1.5.1 United States Pain Relievers Market
9.1.5.1.1 United States Pain Relievers Market by Type
9.1.5.1.2 United States Pain Relievers Market by Application
9.1.5.2 Canada Pain Relievers Market
9.1.5.2.1 Canada Pain Relievers Market by Type
9.1.5.2.2 Canada Pain Relievers Market by Application
9.1.5.3 Mexico Pain Relievers Market
9.1.5.3.1 Mexico Pain Relievers Market by Type
9.1.5.3.2 Mexico Pain Relievers Market by Application
9.2. EUROPE
9.2.1 Europe Pain Relievers Market Overview
9.2.2 Europe Pain Relievers Market Forecasts and Analysis
9.2.3 Europe Pain Relievers Market Forecasts and Analysis - By Type
9.2.4 Europe Pain Relievers Market Forecasts and Analysis - By Application
9.2.5 Europe Pain Relievers Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Pain Relievers Market
9.2.5.1.1 Germany Pain Relievers Market by Type
9.2.5.1.2 Germany Pain Relievers Market by Application
9.2.5.2 France Pain Relievers Market
9.2.5.2.1 France Pain Relievers Market by Type
9.2.5.2.2 France Pain Relievers Market by Application
9.2.5.3 Italy Pain Relievers Market
9.2.5.3.1 Italy Pain Relievers Market by Type
9.2.5.3.2 Italy Pain Relievers Market by Application
9.2.5.4 Spain Pain Relievers Market
9.2.5.4.1 Spain Pain Relievers Market by Type
9.2.5.4.2 Spain Pain Relievers Market by Application
9.2.5.5 United Kingdom Pain Relievers Market
9.2.5.5.1 United Kingdom Pain Relievers Market by Type
9.2.5.5.2 United Kingdom Pain Relievers Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Pain Relievers Market Overview
9.3.2 Asia-Pacific Pain Relievers Market Forecasts and Analysis
9.3.3 Asia-Pacific Pain Relievers Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Pain Relievers Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Pain Relievers Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Pain Relievers Market
9.3.5.1.1 Australia Pain Relievers Market by Type
9.3.5.1.2 Australia Pain Relievers Market by Application
9.3.5.2 China Pain Relievers Market
9.3.5.2.1 China Pain Relievers Market by Type
9.3.5.2.2 China Pain Relievers Market by Application
9.3.5.3 India Pain Relievers Market
9.3.5.3.1 India Pain Relievers Market by Type
9.3.5.3.2 India Pain Relievers Market by Application
9.3.5.4 Japan Pain Relievers Market
9.3.5.4.1 Japan Pain Relievers Market by Type
9.3.5.4.2 Japan Pain Relievers Market by Application
9.3.5.5 South Korea Pain Relievers Market
9.3.5.5.1 South Korea Pain Relievers Market by Type
9.3.5.5.2 South Korea Pain Relievers Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Pain Relievers Market Overview
9.4.2 Middle East and Africa Pain Relievers Market Forecasts and Analysis
9.4.3 Middle East and Africa Pain Relievers Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Pain Relievers Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Pain Relievers Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Pain Relievers Market
9.4.5.1.1 South Africa Pain Relievers Market by Type
9.4.5.1.2 South Africa Pain Relievers Market by Application
9.4.5.2 Saudi Arabia Pain Relievers Market
9.4.5.2.1 Saudi Arabia Pain Relievers Market by Type
9.4.5.2.2 Saudi Arabia Pain Relievers Market by Application
9.4.5.3 U.A.E Pain Relievers Market
9.4.5.3.1 U.A.E Pain Relievers Market by Type
9.4.5.3.2 U.A.E Pain Relievers Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Pain Relievers Market Overview
9.5.2 South and Central America Pain Relievers Market Forecasts and Analysis
9.5.3 South and Central America Pain Relievers Market Forecasts and Analysis - By Type
9.5.4 South and Central America Pain Relievers Market Forecasts and Analysis - By Application
9.5.5 South and Central America Pain Relievers Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Pain Relievers Market
9.5.5.1.1 Brazil Pain Relievers Market by Type
9.5.5.1.2 Brazil Pain Relievers Market by Application
9.5.5.2 Argentina Pain Relievers Market
9.5.5.2.1 Argentina Pain Relievers Market by Type
9.5.5.2.2 Argentina Pain Relievers Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PAIN RELIEVERS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PAIN RELIEVERS MARKET, KEY COMPANY PROFILES
12.1. PFIZER
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ENDO PHARMACEUTICALS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BAYER AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GSK
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ASTRAZENECA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GRUNENTHAL
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ELI LILLY AND COMPANY
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SANOFI
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MERCK
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. PURDUE PHARMA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Pfizer
2. Endo Pharmaceuticals
3. Bayer AG
4. GSK
5. AstraZeneca
6. Grunenthal
7. Eli Lilly and Company
8. Sanofi
9. Merck
10. Purdue Pharma
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For